Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Greg Lucier, Mingfu Zhu

Premium

NuVasive has appointed Greg Lucier to its board of directors. Lucier is chairman and CEO of Life Technologies, which was recently acquired by Thermo Fisher Scientific. Prior to Life Tech, Lucier held several senior management positions at General Electric, most recently as CEO and president of medical systems information technologies for GE Healthcare. He holds a BS in industrial engineering from Pennsylvania State University and an MBA from Harvard Graduate School of Business Administration.


Tute Genomics, which provides a cloud-based clinical genome interpretation pipeline, has appointed Mingfu Zhu as director of bioinformatics.

Zhu was previously an assistant professor at the Center for Human Genome Variation at Duke University Medical Center.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.